ELIZABETH WALKER: Open Payments
NPI 1376943399 · MANALAPAN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$838 in 50 payments from 16 companies in 2025. Trend: 2023 $958 · 2024 $1,285 · 2025 $838
Food & beverage: $838
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 15 | $226 |
| Regeneron Healthcare Solutions, Inc. | 5 | $91 |
| PFIZER INC. | 5 | $83 |
| Incyte Corporation | 3 | $54 |
| Galderma Laboratories, L.P. | 3 | $51 |
| GENZYME CORPORATION | 2 | $48 |
| LEO Pharma Inc. | 3 | $48 |
| Novartis Pharmaceuticals Corporation | 3 | $47 |
| Organogenesis Inc. | 2 | $40 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $36 |
Products named: VTAMA, DUPIXENT, CIBINQO, OPZELURA, LIBTAYO, NEMLUVIO, COSENTYX, ILUMYA.
Industry payments across NJ — which companies pay providers there.
